AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Plexus acquires exclusive position for demographically targeted T-cell vaccine discovery.(Brief Article)
2002 JUL 24 - (NewsRx.com & NewsRx.net) -- Plexus Vaccine, Inc., a San Diego based biotechnology company employing rational drug design principles for vaccine discovery and development, announces that it has established a Danish subsidiary under the name Plexus Denmark Aps.
The Danish subsidiary will assist Plexus in developing new vaccines based on a combination of advanced computational and experimental biochemical methods.
Through a license agreement with the Danish scientists Professor Soeren Brunak and Professor Soeren Buus, Plexus has secured exclusive access to technology that will constitute a cornerstone in the activities of Plexus Denmark and ...
- Plexus Vaccine Acquires Exclusive Position for Demographically Targeted T-cell...
- Press release article from: PR Newswire June 19, 2002 700+ words
...Danish scientists Professor Soeren Brunak and Professor Soeren Buus, Plexus...activities of Plexus Denmark and significantly...Plexus US and Plexus Denmark opens great opportunities...effective vaccines." Professor Soeren Brunak is the...
- SIGA Technologies, Inc. Signs Definitive Agreement to Acquire Assets of Plexus...
- Press release article from: Business Wire May 15, 2003 700+ words
...Inc, including the equity in Plexus's Danish subsidiary Plexus Denmark ApS. The acquisition is a strategic move for SIGA to broaden...products. We intend to have a real impact on world health." Plexus Denmark ApS, Plexus's Danish subsidiary to be acquired by SIGA...
- SIGA and PLEXUS Announce Patent Filed For SARS Rapid Antigen Identification and...
- Press release article from: Business Wire May 20, 2003 700+ words
...a definitive agreement with Plexus to acquire substantially all of the assets of Plexus, including the capital stock of Plexus Denmark APS, a wholly owned subsidiary of Plexus Vaccine Inc. This transaction is subject to customary closing conditions and...
- Deals roundup.
- Newspaper article from: Medical Device Daily May 16, 2003 700+ words
...substantially all of the assets of closely held Plexus Vaccine (San Diego, California), including the equity in Danish unit Plexus Denmark ApS. Financial terms were not disclosed. Completion of the deal is scheduled for the second quarter, subject to closing...
Source: HighBeam Research, Plexus acquires exclusive position for demographically targeted...